Bringing a medical device from prototype to regulatory submission is where many programs stall.
You’ve demonstrated feasibility. Your technology works. But now you need Device Verification (DV) units built under GMP, with traceability, documentation, and manufacturing discipline that will withstand FDA scrutiny.
This is where many innovators discover a structural gap in the contract manufacturing landscape.
The DV Manufacturing Gap
Large contract manufacturers are optimized for stable, high-volume production. Their infrastructure, pricing models, and operational cadence are designed for mature products with locked designs and predictable forecasts.
DV builds are different.
At the Device Verification stage, your product may still require:
- Design refinements following engineering builds
- Design for Manufacturability (DFM) optimization
- Supplier qualification and consolidation
- BOM stabilization
- Controlled engineering change management
- Cost-of-goods modeling and early commercialization planning
Volumes are typically limited — yet the regulatory expectations are high.
For many large CMs, this risk-to-volume ratio simply does not fit their model.
What DV Builds Actually Require
Device Verification builds are not “prototype runs.” They are production-intent builds that must support regulatory submission.
DV units should be manufactured:
- Under GMP in an ISO 13485–certified, FDA-registered facility
- With full material and process traceability
- Under controlled documentation aligned with Design Controls
- With Device History Records (DHRs) and Device Master Records (DMRs) structured for audit readiness
- In alignment with risk management (ISO 14971) and process validation planning
These builds often support:
- 510(k) submissions
- PMA applications
- CE technical documentation
- Verification & Validation (V&V) protocols
- Sterilization validation and packaging validation activities
At this stage, manufacturing execution directly impacts regulatory success.
Pathway’s Focus: DV & Early NPI Manufacturing
At Pathway Medtech, we specialize in low-to-mid volume New Product Introduction (NPI) and DV manufacturing.
Our infrastructure is intentionally structured to support:
- Production-intent DV builds
- DFM and assembly optimization
- Supply chain development and qualification
- Cleanroom manufacturing and sterile barrier system integration
- Process development and IQ/OQ/PQ planning
- Regulatory documentation alignment
We understand that DV builds often surface necessary refinements. Our systems support controlled design evolution without compromising traceability, quality records, or submission timelines.
Rather than forcing early-stage programs into high-volume manufacturing frameworks, we tailor the manufacturing strategy to the realities of your product’s maturity.
Bridging DV to Early Commercialization
After verification, many companies require:
- Pilot launch manufacturing
- Low-volume early commercialization
- Controlled scale-up planning
- Supply chain stabilization
- Preparation for future manufacturing transfer (if applicable)
This bridge phase is critical. Poorly executed early commercialization can inflate cost-of-goods, create validation gaps, and complicate downstream transfer.
We support a structured transition from DV through early commercial production — whether that means scaling with us or preparing for transfer to a higher-volume CM once the product stabilizes.
Why Partner Selection at DV Matters
Choosing the wrong manufacturing partner at the DV stage can lead to:
- Delayed submissions
- Incomplete or misaligned documentation
- Costly design rework
- Validation inefficiencies
- Long-term COGS challenges
Conversely, selecting a partner experienced in early-stage NPI reduces risk and builds a manufacturing foundation that supports regulatory approval and commercialization.
Designed for the Critical Stage Between Prototype and Scale
If your medical device program is entering Device Verification, preparing for a 510(k), PMA, or CE submission, or planning early commercialization, you need more than capacity — you need a manufacturing partner aligned with regulatory realities and evolving design maturity.
Pathway Medtech focuses specifically on that critical inflection point.
From DV builds through early market launch, we integrate engineering, manufacturing, and regulatory alignment to help you move forward with confidence.
